RECENT NEWS

ViroStat is a primary manufacturer of antibody pairs validated for use in enzyme-linked immunosorbent assay (ELISA) and lateral-flow applications. These OEM pairs are currently used in numerous IVD products for antigen detection.

The Health and Care Professions Council (HCPC) has unveiled its new Corporate Strategy, setting out a bold agenda for the next five years and a clear vision for the future.

On 24 February, Tecan will mark 20 years since publication of the draft sequence of the human genome by hosting its first virtual genomics symposium. This one-day event will be live-streamed using a sophisticated new online platform.

A webinar to be held on 21 January (2.00 pm) to include a presentation of Menarini’s different offerings in surgical specimen management as well as a live demonstration of these instruments. Click on this story for the link to register.

Diagnostica Stago has developed an automated test set-up to enable monitoring of the new, highly-active haemophilia drug emicizumab. The new protocol also eliminates any carry-over concerns.

Sysmex’s haematological inflammation parameters support early diagnosis so that targeted treatment can be started, changed or modified. Monitoring patients with inflammatory diseases and the success of their therapy helps to avoid antibiotic overuse.

Roche has announced the CE-IVD launch of its automated digital pathology algorithms uPath HER2 (4B5) image analysis and uPath Dual ISH image analysis for breast cancer to help determine the best treatment strategy for each patient.

The SHOT team will host its first webinar of 2021 on 28 January, 1400–1500 GMT, and cover the Avoidable, Delayed or Under/Overtransfusion (ADU) chapter of the Annual SHOT Report 2019. Click on this story for the link to register.

Proscia, a provider of digital and computational pathology solutions, has announced that Laboratorium Pathologie Oost-Nederland (LabPON), the first laboratory in the world to 100% digital pathology diagnosis, will deploy its Concentriq platform.

A new textbook entitled ‘Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives’ explains immunotherapies for different types of cancer, helping users carry out research or create alternatives for drug development.

New research on the structure and dynamics of a branched form of DNA called a three-way junction could lead to more effectively targeted treatments for degenerative disorders like Huntington’s disease.

Proteomedix, the Swiss cancer diagnostics company, has announced that the results of PROPOSe, a prospective multicentre study of Proclarix in clinical routine use, have been published in European Urology Oncology.

Scientists have solved a key parasitic puzzle, revealing the unique and complex structures toxoplasmosis and malaria parasites make in order to survive in different hosts.

Following the success of the first Global Image of the Year Life Science Light Microscopy Award, Olympus has launched its second annual Global Image of the Year Award to recognise the best in life science imaging.

Bruker Corporation and Evosep have announced major progress in high-sensitivity, quantitative true single-cell proteomics, using a modified timsTOF Pro mass spectrometer connected to an Evosep One low-flow chromatography system.

A new textbook entitled Evolutionary Diversity as a Source for Anticancer Molecules discusses evolutionary diversity as a source for anticancer agents derived from bacteria, algae, bryophytes, pteridophytes, and gymnosperms.

The past year has proved challenging for readers, contributors and commercial colleagues alike; however, the team responsible for publication of Pathology in Practice looks forward with some confidence to a better 2021.

Debra Padgett has been confirmed as the IBMS President-Elect, a position that took effect from 1 January 2021. She will work with the current President, Allan Wilson, and will succeed him as President on 1 January 2022.

Joshua Walker, Export Manager at Priorclave, has won the Gambica 2020 Young Talent of the Year Award.

ProPath has announced the addition of SS18-SSX to its antibody library. It is a fusion-specific antibody that is highly sensitive (95%) and specific (100%) for the detection of synovial sarcoma.